Skip to main content

 

 

Main menu

  • Home
  • Article
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews Collection
    • Pillars of Immunology Collection
    • Translating Immunology Collection
    • Annual Meeting Abstracts
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Rights and Permissions
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Article
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews Collection
    • Pillars of Immunology Collection
    • Translating Immunology Collection
    • Annual Meeting Abstracts
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Rights and Permissions
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Macrophage Metalloelastase as a Major Factor for Glomerular Injury in Anti-Glomerular Basement Membrane Nephritis

Yoshikatsu Kaneko, Minoru Sakatsume, Yuansheng Xie, Takeshi Kuroda, Michiko Igashima, Ichiei Narita and Fumitake Gejyo
J Immunol March 15, 2003, 170 (6) 3377-3385; DOI: https://doi.org/10.4049/jimmunol.170.6.3377
Yoshikatsu Kaneko
Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; and Kidney Center and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Minoru Sakatsume
Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuansheng Xie
Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeshi Kuroda
Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michiko Igashima
Department of Pathology, Shinraku-en Hospital, Niigata, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ichiei Narita
Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fumitake Gejyo
Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Photomicrographs of representative kidney sections from rats with anti-GBM nephritis on days 1 (B), 3 (C), and 7 (D and E) after the injection of anti-GBM serum, or from untreated normal rat (A). Paraffin sections were stained with PAS (A–D) or PAM (E). B, No remarkable change except for slight endocapillary proliferation was observed on day 1 (arrow). C, Increased hypercellularity was apparent in some glomeruli on day 3. D, Severe crescent formation with fibrin deposit (arrow) and mesangial cell proliferation were observed in about one-half of the glomeruli. E, Rupture of Bowman’s capsule (arrow) and capillary tuft (arrowhead) was observed. (Original magnifications, ×200.)

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Northern blot analysis of rat MMP-12 mRNA in the kidneys of anti-GBM nephritis rats. Total RNA (20 μg) purified from kidneys in untreated normal rat, anti-GBM nephritis rat killed on days 1, 3, and 7, or control serum-administered rat killed on days 1, 3, and 7 was hybridized with alkaline phosphatase-labeled rat MMP-12 cDNA probe.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    In situ hybridization of rat MMP-12 mRNA in the kidneys of anti-GBM nephritis rats. RNA in the kidneys on paraffin sections from anti-GBM nephritis rats killed on days 7 (A–D, H, and I), 3 (E), and 1 (F), or from untreated normal rat (G) was hybridized with Dig-labeled rat MMP-12 cRNA probe, and the macrophage marker was detected with anti-rat ED-1 mAb. A, mRNA in multinuclear giant cells forming crescent in the glomerulus was hybridized with antisense cRNA probe (blue). B, Sense cRNA probe was used as a control. C, Macrophages and multinuclear giant cells were stained with anti-rat ED-1 mAb (brown) after the hybridization with antisense cRNA probe (blue). D, Serial section was stained with PAS. MMP-12 mRNA was mildly expressed in macrophages infiltrated into some glomeruli on day 3 (E), but not in the kidney on day 1 or normal control (F, G). H, MMP-12 mRNA was detected in most of the glomeruli with crescent (arrow), but not in the glomeruli, with only mild proliferative change (arrowhead). I, MMP-12 mRNA was not detected in the macrophages infiltrated within the interstitium. (Original magnifications: A–G, ×200; H and I, ×100.)

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    A, Western blot analysis with anti-rat rMMP-12 Ab. Rat rMMP-12 (0.5 μg) was resolved by SDS-PAGE, transferred to a polyvinylidene difluoride membrane, and incubated with anti-rat rMMP-12 Ab or rabbit control IgG, followed by incubation with peroxidase-conjugated goat anti-rabbit IgG Ab. B, In vitro digestion of natural substrates by rat rMMP-12, and inhibition of its digestive effect by anti-rat rMMP-12 Ab. Ten micrograms of human fibronectin was incubated with 0.2 μg of rat rMMP-12, with or without anti-rat rMMP-12 Ab at room temperature for 16 h, and analyzed by 5% SDS-PAGE. Fibronectin was completely degraded by incubation with rat rMMP-12. Two micrograms of anti-rat rMMP-12 Ab inhibited the digestive effect of rat rMMP-12 almost completely, and the inhibition was dose dependent. Same dose of control IgG did not inhibit the digestion. C, Fifty micrograms of bovine solubilized elastin was incubated with 4 μg of rat rMMP-12, with or without anti-rat rMMP-12 Ab at room temperature for 16 h. After intact elastin or Ab was precipitated with trichloroacetic acid, 100 μl of supernatant containing released peptides was blended with 100 μl of ninhydrin reagent, and was quantitatively measured as an absorbance at 570 nm after dilution with 800 μl of 50% (v/v) ethanol. Released peptides besides background release were reduced by 57% by addition of 10 μg of anti-rat rMMP-12 Ab. Values are mean ± SEM in triplicate samples; ∗, p = < 0.0001 vs released peptides from digested elastin by rat rMMP-12 without blocking.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Immunohistochemical analysis of the kidney in anti-GBM nephritis rats with anti-rat rMMP-12 Ab. Serial paraffin sections from anti-GBM nephritis rat killed on day 7 were stained with anti-rat rMMP-12 Ab (A, D, E), or rabbit control IgG (B), or stained with PAS (C). A, Large granules in the cytoplasm of the crescent-forming cells or multinuclear giant cells were stained with anti-rat rMMP-12 Ab (red). D, Double staining with anti-rat ED-1 mAb (brown) and anti-rat rMMP-12 Ab (red). MMP-12 was detected in ED-1-positive cells in the glomeruli with severe crescent. E, These cells containing MMP-12 were seen in several glomeruli with severe crescentic formation (arrow), but not in the glomeruli almost intact or with mild proliferative change (arrowhead). (Original magnifications: A–D, ×200; E, ×100.)

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Photomicrographs of representative kidney sections from rats with anti-GBM nephritis treated with anti-rat rMMP-12 Ab (A, C) or control Ig (B, D) on days 0, 2, 4, and 6 after the injection of anti-GBM antiserum. The kidneys were removed on day 7. Paraffin sections were stained with PAM (A, B) or anti-rat ED-1 mAb (C, D). In these sections, numbers of glomeruli with crescent (arrow) were 1 of 10 (A), and 7 of 9 (B). Only several numbers of ED-1-positive cells (brown) per glomerulus were counted in the kidney of the rat treated with anti-rat rMMP-12 Ab (C), in contrast to 10–40 of ED-1-positive cells per glomerulus in the kidney of the rat treated with control Ig (D). (Original magnifications: ×40.)

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    Effect of anti-rat rMMP-12 Ab administration in anti-GBM nephritis rats. A, Percentages of glomeruli with crescent, and numbers of macrophages or CD8+ cells per glomerulus of the kidneys from each of six anti-GBM nephritis rats treated with anti-rat rMMP-12 Ab (filled bars) or control Ig (open bars). Rats were injected with 5 mg of anti-rat rMMP-12 Ab or control Ig on days 0, 2, 4, and 6, and the kidneys were removed on day 7. Percentages of glomeruli with crescent were determined on 100 glomeruli per kidney with paraffin sections stained with PAM, and numbers of macrophages and CD8+ cells per glomerulus were counted on 30 glomeruli per kidney after staining macrophages with anti-rat ED-1 mAb or anti-rat CD8 mAb. Values are mean ± SEM; ∗, p = 0.0036; ∗∗, p = 0.0039; ∗∗∗, p = 0.0542 vs anti-GBM nephritis rats treated with control Ig. B, Urine was collected for 24 h on day 6–7 from each of six anti-GBM nephritis rats treated with anti-rat rMMP-12 Ab (filled bars) or control Ig (open bars), housed in metabolic cages. Sera were collected on day 7. Results were expressed as the ratio of urine protein to urine creatinine, daily proteinuria, and creatinine clearance. Values are mean ± SEM; ∗, p = 0.0039; ∗∗, p = 0.0104 vs anti-GBM nephritis rats treated with control Ig.

Tables

  • Figures
    • View popup
    Table I.

    Genes with elevated expression in the kidney of anti-GBM nephritis rats more than 6-fold compared with those in control rats on day 1a

    Gene NameAccession NumberAVD of ControlFold Change of AVD
    Day 1–1Day 1–2
    Ig germline κ-chain C regionM18529254.8, A6.36.4
    • a Expression levels of the two individual rats are presented as fold change of average differences compared with those of control rats. When the detection p value was >0.06, it was determined to be absent (A). The accession number is the GenBank entry. AVD, average difference.

    • View popup
    Table II.

    Genes with elevated expression in the kidney of anti-GBM nephritis rats more than 6-fold compared with those in control rats on day 3a

    Gene NameAccession NumberAVD of ControlFold Change of AVD
    Day 3–1Day 3–2
    Macrophage metalloelastaseX98517508.6, A15.918.1
    IL-1βM98820782.4, A9.06.7
    Plasminogen activator inhibitor-1M24067772.0, A8.810.2
    Wee 1 tyrosine kinaseD31838221.3, A8.36.2
    Immediate-early serum-responsive JE geneX170531920.57.26.8
    UDP glucuronosyltransferaseD38062288.4, A6.67.2
    EST232720AI236158753.26.17.3
    • a Expression levels of the two individual rats are presented as fold change of average differences compared with those of control rats. When the detection p value was >0.06, it was determined to be absent (A). The accession number is the GenBank entry. AVD, average difference.

    • View popup
    Table III.

    Genes with elevated expression in the kidney of anti-GBM nephritis rats more than 6-fold compared with those in control rats on day 7a

    Gene NameAccession NumberAVD of ControlFold Change of AVD
    Day 7–1Day 7–2
    Macrophage metalloelastaseX98517184.0, A36.737.3
    SM22M83107288.316.729.2
    Kidney injury molecule-1AF035963231.3, A10.726.2
    Major acute phase α-1 proteinK02814653.6, A9.915.7
    Fc-γ receptorX73371239.38.08.5
    Plasminogen activator inhibitor-1M240671037.47.46.0
    Complement protein C1q β-chainX711271071.2, A7.212.1
    Immediate-early serum response JE geneX170531630.46.79.5
    MMP-9U24441509.3, A6.58.8
    • a Expression levels of the two individual rats are presented as fold change of average differences compared with those of control rats. When the detection p value was >0.06, it was determined to be absent (A). The accession number is the GenBank entry. AVD, average difference.

    • View popup
    Table IV.

    Serum anti-rabbit Ig Ab levels in the anti-GBM nephritis rats treated with anti-rMMP-12 Ab, with control Ig, or without any further administration of rabbit Iga

    GroupELISA (OD450)
    Anti-rMMP-12 Ab0.094 ± 0.015
    Control Ig0.134 ± 0.016
    No further treatment0.158 ± 0.002
    • a Sera were collected on day 7 from anti-GBM nephritis rats treated with anti-rMMP-12 Ab (n = 6), with control Ig (n = 6), or without any further administration of rabbit Ig (n = 3). Results are expressed as mean ± SEM. Differences of each value are not significant. Negative control, 0.051 ± 0.002; positive control, 1.183 ± 0.002.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 170 (6)
The Journal of Immunology
Vol. 170, Issue 6
15 Mar 2003
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Macrophage Metalloelastase as a Major Factor for Glomerular Injury in Anti-Glomerular Basement Membrane Nephritis
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
Citation Tools
Macrophage Metalloelastase as a Major Factor for Glomerular Injury in Anti-Glomerular Basement Membrane Nephritis
Yoshikatsu Kaneko, Minoru Sakatsume, Yuansheng Xie, Takeshi Kuroda, Michiko Igashima, Ichiei Narita, Fumitake Gejyo
The Journal of Immunology March 15, 2003, 170 (6) 3377-3385; DOI: 10.4049/jimmunol.170.6.3377

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Macrophage Metalloelastase as a Major Factor for Glomerular Injury in Anti-Glomerular Basement Membrane Nephritis
Yoshikatsu Kaneko, Minoru Sakatsume, Yuansheng Xie, Takeshi Kuroda, Michiko Igashima, Ichiei Narita, Fumitake Gejyo
The Journal of Immunology March 15, 2003, 170 (6) 3377-3385; DOI: 10.4049/jimmunol.170.6.3377
Permalink:
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Differential Susceptibility to Staphylococcal Superantigen (SsAg)-Induced Apoptosis of CD4+ T Cells from Atopic Dermatitis Patients and Healthy Subjects: The Inhibitory Effect of IL-4 on SsAg-Induced Apoptosis
  • HIV-1 Vaccination Administered Intramuscularly Can Induce Both Systemic and Mucosal T Cell Immunity in HIV-1-Uninfected Individuals
  • Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis
Show more CLINICAL IMMUNOLOGY

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews Collection
  • Pillars of Immunology Collection
  • Translating Immunology Collection

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2017 by The American Association of Immunologists, Inc.

Print ISSN: 0022-1767        Online ISSN: 1550-6606